The elevated expression of SLC14A1, phospho-Smad2, and Snail not only corroborates their synergistic interaction but also underscores their potential as significant biomarkers and therapeutic targets for managing CRC progression and metastasis. The gene discussed is SLC14A1; the disease is colorectal carcinoma.